Australia adopts European biosimilar guidelines

The TGA has adopted several European biosimilar guidelines, including one on the non-clinical and clinical requirements for similar biological medicinal products containing monoclonal antibodies. The guideline was released by the European Medicines Agency in 2012 and establishes the “general principles” of a development program to test the comparability of a biosimilar product to an innovator ...

Already a member?

Login to keep reading.

© 2021 the limbic